Our News
SMERemediumCap invests in the equity capital of AROSIS
Posted: December 12, 2022
The investment fund SMERemediumCap (SMERC) is pleased to announce that, on 7 December 2022, it completed an agreement with the Fotiadis family, the principal shareholders of AROSIS, for the acquisition of a strategic equity stake in the company and its capital strengthening through the issuance of a convertible bond loan.
AROSIS is a steadily growing company that has been active primarily in the pulses sector in Greece for the past 66 years, offering high-quality pulse products sourced from Greek farmers, with production facilities located in the Kastoria region.
Η επενδυτική φιλοσοφία του SMERemediumCap II
The AROSIS brand is closely associated with Greek land and tradition, offering premium-quality pulses such as PGI Kastoria giant beans and Grevena lentils, among others.
The combination of quality and exceptional taste, the company’s long-standing, trust-based relationship with Greek farmers, and the many years of credible presence of its shareholders and management in the Greek market, led foremost by AROSIS, ensure that the company delivers authentic Greek products to the table of every family every day, with respect for tradition, the hard work of local producers and the land they cultivate.
The investment fund SMERemediumCap and the principal shareholder of AROSIS, Tryfonas Fotiadis, share a common vision for the company’s dynamic growth on solid foundations, while remaining firmly committed to tradition and quality. The objective is for AROSIS products to reach more households across Greece, while at the same time developing a strong and credible sales network abroad, preserving intact the values and traditions of our country.
Διακυβέρνηση και ομάδα
Both parties are committed to working closely on the implementation of an ambitious business plan. Mr Tryfonas Fotiadis will remain in his role as Chief Executive Officer and will lead the company’s investment and growth programme, ensuring the uninterrupted continuation of its upward trajectory and the preservation of the high product quality that has long distinguished the company. This outcome will be further reinforced by the dedication, hard work and experience of the company’s employees.
The primary business objective of the investment is the creation of a pioneering, market-leading food organisation, achieved through both organic growth and new investments and partnerships, offering a broad range of high-quality products across the wider pulses sector.
Mr Tryfonas Fotiadis, Chief Executive Officer of the company, noted:
“Over the past years, AROSIS has recorded a strong upward trajectory, marked by significant investments, growth and solid financial performance. It has achieved this despite successive crises, thanks to the strength of its people, whose dedication and talent are unparalleled. As a third-generation member of the company, I would like to thank my tireless mother, Eleni Fotiadou, who for 56 years has been a beacon of inspiration and commitment for all of us. We are honoured that the investment fund SMERemediumCap is investing in AROSIS, and it is our responsibility to live up to the trust it has placed in us. Looking ahead, we can further consolidate our position in Greece, expand our footprint internationally, and intensify our innovation efforts for the benefit of our new shareholders, our people, and the Greek regions and communities in which we operate.”
About SMERemediumCap
SMERemediumCap, supported by an experienced investment team, is the first investment fund in Greece to focus on mid-sized Greek productive companies with strong prospects for growth and business recovery. The Fund has raised and manages capital of €143 million from 42 institutional, corporate and private investors, including distinguished Greek and international institutional investors, pension funds, insurance companies and family offices. The Executive Chairman of SMERemediumCap is Nikolaos Karamouzis.